Increasing demand for structural heart devices form the hospitals and ambulatory surgical centers sectors is major factor expected to drive growth of the global structural heart devices market over the forecast period.

The global structural heart devices market report has been segmented on the basis of product type, indication, end user, and region.

On the basis of product type, the global structural heart devices market has been segmented into heart valve, annuloplasty rings, and occlusion devices. The heart valve segment is sub-segment into transcatheter heart valve, mechanical heart valve, and surgical heart valve. The heart valve segment is expected to account for major share in terms of revenue in the global structural heart devices market, owing to increasing demand for structural heart devices from healthcare industry. The heart valve segment revenue is also anticipated to register highest CAGR over the forecast.

On the basis of indication, the global structural heart devices market has been segmented into valvular heart disease, cardiomyopathy, and congenital heart defects. The valvular heart disease segment is sub-segment into regurgitation and stenosis. The valvular heart disease segment is expected to account for significant share in the global structural heart devices market in terms of revenue. The congenital heart defects segment revenue is anticipated to register highest CAGR over the forecast.

On the basis of region, the global structural heart devices market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Request for the Sample Report Here: https://marketresearch.biz/report/structural-heart-devices-market/request-sample/

North America market is estimated to dominate with significant revenue share in the global structural heart devices market in 2017. Asia Pacific market is anticipated to register highest CAGR in terms of revenue in next 10 years, owing to increasing demand from healthcare industry in the countries in this region.

Key players operating in the global market include Medtronic plc, St. Jude Medical, Inc., Boston Scientific Corporation, CardioKinetix, Inc., Comed B.V., Edwards Lifesciences Corporation, LivaNova PLC, Abbott Laboratories Inc., JenaValve Technology, Inc., and Biomerics, LLC.

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: